Chlamydia and Mycoplasma Antibodies and Ovarian Tumors
Author Information
Author(s): Idahl Annika, Lundin Eva, Jurstrand Margaretha, Kumlin Urban, Elgh Fredrik, Ohlson Nina, Ottander Ulrika
Primary Institution: Umeå University
Hypothesis
Are Chlamydia trachomatis and Mycoplasma genitalium antibodies associated with epithelial ovarian tumors?
Conclusion
Chlamydial HSP60-1 IgG and M. genitalium IgG antibodies are associated with certain types of ovarian tumors, suggesting a link between infections and tumor development.
Supporting Evidence
- Chlamydial HSP60-1 IgG antibodies were associated with type II ovarian cancer in women with samples taken more than a year before diagnosis.
- M. genitalium IgG antibodies were associated with borderline ovarian tumors.
- Overall, no associations were found between antibodies and epithelial ovarian cancer.
Takeaway
This study looked at whether certain germs in the body are linked to ovarian tumors. It found that some germs might be connected to specific types of tumors.
Methodology
Plasma samples from women undergoing surgery for suspected ovarian issues were analyzed for specific antibodies.
Potential Biases
Incomplete data on clinical characteristics may reduce the ability to correct for potential confounders.
Limitations
The study had a small number of subjects with eligible plasma samples, making subgroup analysis difficult.
Participant Demographics
Women undergoing surgery for suspected ovarian pathology, primarily from Västerbotten County, Sweden.
Statistical Information
P-Value
0.002 for cHSP60-1 IgG with type II tumors; 0.01 for M. genitalium IgG with borderline tumors.
Confidence Interval
95% CI: 76.2%–82.4% for C. pneumoniae IgG prevalence.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website